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The apolipoprotein E (APOE) epsilon 4 isoform has been associated with a significantly greater risk of 
developing late onset Alzheimer’s disease (AD). However, the negative effects of APOE-ε4 allele on 
cognitive function vary across the lifespan: reduced memory and executive function have been found in 
older individuals but, paradoxically, young APOE-ε4 carriers perform better on cognitive tests and show 
higher neural efficiency. This study aimed to assess the association between APOE genotype and 
saccade latency using a prosaccade and antisaccade task in young individuals (N=97, age: 17-35 years). 
Results showed that prosaccade latency was significantly delayed in a group of ε4 carriers in comparison 
to non-carriers, which was due to a lower rate of signal accumulation rather than a change in the 
criterion threshold. In contrast, there was no significant genotype difference for antisaccade latency in 
this young cohort. These results indicate that prosaccade latency may be useful in establishing the APOE 
















The apolipoprotein E (APOE) gene is a significant genetic risk factor for Alzheimer’s disease (AD) [1]. 
However, the physiological mechanisms involving the APOE genotype in normal and pathological 
aging have not been fully established. APOE is involved in the regulation of lipid transport, storage, and 
metabolism in the peripheral and central nervous system [2-4]. There are 3 common alleles of the APOE 
gene: ε2, ε3, and ε4, resulting in 6 genotypes: 3 homozygotes, and 3 heterozygotes (ε2/ε3, ε2/ε4, ε3/ε4). 
The three isoforms vary in their effectiveness to bind lipids and transport them across the cell 
membrane, such that the ε4 allele is the least effective. Consequently, presence of the ε4 allele has been 
associated with increased amyloid-β (Aβ) peptide aggregation and tangle formation in the brain, reduced 
neurogenesis, increased neuronal toxicity, and impaired cholinergic function [4].  Epidemiological 
studies have shown that presence of the ε4 allele is associated with a dose-dependent increased risk of 
AD [5]. For example, the odds of AD are 2.7- to 3.2-fold higher in Caucasian individuals with ε3/ε4 
relative to the ε3/ε3 genotype, whereas the odds increase 12.5-14.9 times for ε4/ε4 heterozygotes. 
Because the pathogenesis of AD is complex and involves multiple physiological mechanisms [6], it is 
important to have a better understanding of how the APOE genotype affects different cognitive 
functions. Moreover, establishing an association between the APOE genotype and the corresponding 
behavioural phenotype across the lifespan can assist with distinguishing between normal and 
pathological aging. Eye movements provide a sensitive assay to assess a variety of cognitive functions, 
including decision making and attention [7-10], and could be used to establish the cognitive phenotype. 
Therefore, the aim of the current study was to assess the association between APOE genotype and 
saccade latency in healthy young adults. Such knowledge can assist with identifying individuals who are 
more likely to experience reduced cognitive function with age, and developing targeted interventions 
that could be delivered early to slow disease progression, improve quality of life, and reduce the 













Establishing the cognitive phenotype associated with the ε4 allele in younger individuals is an 
important step towards identifying those who might be at a greater risk of age-related cognitive decline 
later in life. The APOE-ε4 genotype has multiple negative effects on normal brain function, independent 
of the Aβ aggregation, including reduced myelination, mitochondrial dysfunction, and impaired 
cholinergic function [6]. A recent systematic review that included 36 studies which investigated the 
behavioural  effects of APOE-ε4 in mid-adulthood highlighted the complex interaction between APOE 
genotype and age on cognitive functions [11]. In general, studies that used paper and pencil clinical test 
batteries showed no significant differences between apparently healthy ε4 carriers and non-carriers 
across different cognitive domains, such as executive function, memory, visuospatial, and language 
abilities. In contrast, studies that used computerized testing showed that ε4 carriers tend to perform 
worse on tests of attention, episodic memory, and working memory, specifically under conditions of 
increased cognitive load. The detrimental effects of the ε4 allele were detected in the second half of the 
5th decade, with an accelerated rate of decline in the 6th decade revealed by longitudinal studies. Even 
more intriguing are findings from studies that focused on young individuals (<30 years old) where the ε4 
carriers performed significantly better on tests of executive function, attention, and memory, which 
supports the antagonistic pleiotropy hypothesis [12-17]. According to this hypothesis, certain genes 
affect several traits which may have a differential effect on health across the lifespan, hence, the ε4 
allele could have a positive effect on cognitive function in young carriers but the opposite effect in older 
carriers [12, 18]. To summarize, the effects of APOE genotype on cognitive functions across the 
lifespan, and its interaction with conditions that can influence brain health remains to be established – 
especially in the younger individuals.  
One behavioural approach that has proven useful in providing insight into cognitive functions is 













executive functions, such as attention [19-21], working memory [22-24], and inhibition [25] in normal 
and pathological cohorts. An important advantage of studying eye movements is that the neural 
networks involved in their generation have been largely mapped out [26-30], and 
computational/statistical models that explain behavior have been developed and tested [31, 32]. For 
example, Carpenter’s LATER (Linear Approach to Threshold with Ergodic Rate) model has been used 
successfully over the past 37 years to explain neural decision making based on the latency distribution of 
saccadic eye movements [33]. According to the LATER model, eye movements are initiated when the 
afferent signal reaches a threshold criterion, and a delayed response can be caused by two factors: 
change in the criterion level or a decreased rate of signal accumulation. Examining the reciprocal of 
saccade latency distribution provides insight into which of the two factors underlies the delay in saccade 
latency. Specifically, the reciprocal distribution can be described by two parameters: mean (µ) and 
variance (σ2), and changes in these parameters have specific interpretations: changes in µ are associated 
with the rate of signal accumulation, and changes in σ are associated with the baseline activation and/or 
threshold criterion.  Using the LATER model to analyse saccade latency distributions thus provides 
insight into the decision-making process.  
Despite the potential advantage of using eye movements to study the effects of APOE-ε4 on 
cognitive function, surprisingly few studies have taken this approach. A notable exception is the study 
by Velichkovsky et al [34], which examined antisaccade latency – a measure of inhibition control 
dependent on the integrity of the prefrontal cortex – but found no genotype differences in a cohort of 
middle age (50 years old) participants. Our investigation extends this work by assessing the effect of 
APOE-ε4 genotype on saccade latency using both, a prosaccade and antisaccade task in large cohort of 
young adults. The rationale for choosing a prosaccade task is rooted in neurobiology, in particular, the 













nucleus (PPTN) in the brainstem is a major source of cholinergic neurons with reciprocal connections 
with the intermediate/deep layers of the superior colliculus and the basal ganglia nuclei involved in 
saccade generation [29]. Elegant studies by Kobayashi et al using in vitro and in vivo approaches 
showed that signal transmission in the direct visuomotor pathway involving the superior colliculus is 
gated by cholinergic inputs from the PPTN [35]. Specifically, administration of nicotine or acetylcholine 
(Ach) reduced saccade latency [36]. In contrast to the work by Kobayashi et al, pharmacological studies 
with humans provide mixed evidence for the effect of nicotine on saccade latency. Specifically, no 
effects of nicotine were found for prosaccade latency among healthy control participants in studies with 
patients with schizophrenia [37, 38]. On the other hand, studies that examined the effect of nicotine on 
antisaccade performance reported reduced errors [38], decreased latency [39], or both [40]. Interestingly, 
the study by Rycroft and colleagues found a comparable reduction in antisaccade latency following 
administration of nicotine and modafinil, which is a noradrenergic agonist [39]. The authors considered 
several mechanisms that could explain the common effect of nicotine and modafinil, and concluded that 
the action of nicotine on antisaccade performance might not be necessarily modulated solely by the 
cholinergic system.  
To summarize, planning and execution of different types of eye movements is mediated by the 
cholinergic system. Evidence from non-human primates indicates that prosaccade latency is influenced 
by direct stimulation of the cholinergic brainstem neurons. In contrast, human pharmacological studies 
found no effect of nicotine on prosaccades, but antisaccade performance was improved. On the other 
hand, reduced cholinergic function has been found in both normal, and AD diagnosed post-mortem 
brains of individuals with APOE-ε4 genotype [41, 42]. Given the contribution of the cholinergic system 
to oculomotor control, it is important to develop a better understanding of the effects of APOE genotype 













prosaccade and antisaccade latency. We hypothesized that saccade latency will be delayed in our cohort 
of young ε4 allele carriers.  
Methods 
2.1  Participants 
A sample of convenience was recruited from the undergraduate and graduate student population at the 
University of Waterloo (52 males/58 females; mean age = 22.7 years; SD 3.2 years; range 18-35 years). 
Ninety seven participants were recruited using posters placed across the university campus. All 
participants completed the University of Waterloo healthy history questionnaire, which contained 
questions regarding general health, concussion history, and symptoms experienced in the past 6 months. 
There were 27 participants with a history of sports-related concussion who at the time of testing were 
asymptomatic and cleared to participate in sport activities by a medical doctor. Therefore, these 
participants were included in the study. The final sample included in the analysis consisted of 86 
Caucasian and 11 Asian participants. Participation in the study was voluntary and participants did not 
receive remuneration. The study’s protocol was approved by the University of Waterloo Research Ethics 
Board Committee (ORE#19965), and consent was obtained prior to beginning the experiment. 
2.2  Genotyping 
Ninety-seven out of the one hundred and ten recruited participants were eligible- and agreed to provide a 
saliva DNA sample for analysis of two single nucleotide polymorphisms (rs429358 and rs 7412) on the 
apolipoprotein E (APOE) gene. Samples were analyzed using Taqman® SNP genotyping assays 
(Applied Biosystems, Mississauga, Ontario, Canada). Briefly, ~10 ng of genomic DNA was mixed into 
a 10 µl final volume containing 5 µl of Accustart Genotyping Toughmix (QuantaBiosciences, Beverly, 













comprised of 18 Mega-ohm water. Samples were amplified in a CFX96 Real-time PCR detection 
machine (Bio-Rad Laboratories, Mississauga, Ontario, Canada) using the following conditions: 1 cycle 
at 95°C for 5 min followed by 40 cycles alternating between 95°C for 5 s and 60°C for 30 s. APOE 
genotype runs included negative controls lacking DNA template. Duplicate analyses were run on 
approximately 20% of samples for quality control purposes and this generated 100% concordance of 
calls. Genotyping was performed by researchers blinded to behavioural results. Participants were not 
informed about their genotype by the researchers. Instead, they had an option of having their results sent 
to their primary physician; however, none of the participants requested this option. 
2.3  Experimental procedure  
Participants completed two oculomotor tests: prosaccades and antisaccades, which were performed in 
separate blocks, counterbalanced across participants. Oculomotor testing was conducted in a quiet, well-
lit room. Participants were seated 80 cm from a 19’’ CRT monitor (ViewSonic CRT monitor, resolution 
1024x768, refresh rate 85 Hz) with their chin placed in a chinrest. Eye position data were recorded at a 
sampling frequency of 250 Hz using the EyeLink II eye-tracker (SR Research, Ontario, Canada). A 5-
point calibration method was used to calibrate the eye-tracker using a pupil-only collection mode. 
Validation of eye tracking was performed after the calibration, where the validation acceptance criterion 
was set at <1º error to ensure reliability. 
The experimental procedure was created using the Experiment Builder software (ver. 1.8; SR 
Research, Ontario, Canada). The visual stimuli were black and they were presented on a white 
background. At the beginning of each trial participants were instructed to fixate on a central fixation 
cross (stimulus size 0.25º) which was presented at eye level. Fixation stimulus duration was randomized 
between 1500 and 2250 ms. As fixation disappeared, a peripheral target (stimulus size 0.25º) was 













participants were instructed to move their eyes to the peripheral target as quickly possible. In contrast, 
they were instructed to move their eyes in the opposite direction from where the target was displayed in 
the antisaccade task. Participants completed 50 trials in the prosaccade task. Directional errors were 
expected in the antisaccade task, therefore, 60 trials were completed. 
2.4  Data Analysis  
Chi-squared analysis was conducted first to determine whether a history of concussion was associated 
with the APOE genotype. Prior to testing our main hypothesis, a two sample t-test was conduced to test 
for potential differences in saccade latency among participants with and without a concussion history. 
All eye movement data were analysed offline using the eyetracker’s Data Viewer software (ver 
1.8; SR Research, Ontario, Canada). Eye position data from each trial were plotted and visually 
inspected. Trials were excluded if a blink or loss of eye tracking occurred 250 ms prior to or 500 ms 
following target presentation (8% trials: <1% of trials were anticipatory [i.e., latency <80 ms], the 
majority of trials were rejected due to blinks and loss of tracking; range across participants 0-16%). Eye 
movements were detected using a saccade detection algorithm implemented in Data Viewer: 30º/s 
velocity threshold, and 8000º/s2 acceleration threshold. The analysis focused on primary saccade 
latency, which was defined as the interval following target presentation to saccade initiation. Only 
saccades made in the correct direction in the antisaccade task (i.e., away from the target) were included 
in the latency analysis.  
The main hypothesis was tested using two approaches. First, latency data were averaged across 
the trials for each participant and task. Next, data were submitted to analysis of variance (ANOVA) with 
genotype as the between subject factors. Because of unequal number of participants in each genotype 













approach was based on the LATER model developed by Carpenter [43]. SPIC software (available at 
http://www.cudos.ac.uk/later.html) was used to analyse the saccade latency distributions obtained from 
each participant and task. Kolmogorv-Smirnov test was used to confirm model’s goodness of fit. Two 
parameters were extracted to characterize each participant’s latency distribution: mean µ and variance 
σ2.  These two outcome measures were subsequently submitted to an ANOVA with genotype as the 
between subject factor. 
Statistical analyses were conducted using the Statistical Analysis System (SAS) Studio, ver. 3.5 
Enterprise Edition (SAS Institute Inc., Cary, NC, USA). Descriptive statistics are reported as the mean 
and standard deviation, as well as the median and interquartile range (IQR). 
 
3 Results  
3.1 Genotyping 
The distribution of APOE genotypes for the cohort tested in this study is shown in Table 1. The allelic 
frequency was ε2 (6.2%), ε3 (74.2%) and ε4 (19.6%). The distribution of APOE alleles was consistent 
with Hardy-Weinberg equilibrium, Chi2 (df=3) = 4.96, p>0.05 [44][44][44][44][44][44] [calculator can 
be found at the following website: http://www.husdyr.kvl.dk/htm/kc/popgen/genetik/applets/kitest.htm]. 
Due to a small number of participants with less common alleles, our main analysis focused on 
comparing APOE-ε4 carriers and non-carriers. There were 62 participants who did not carry the ε4 
allele, and 35 participants who were ε4 carriers.  
There was no significant difference in APOE-ε4 carrier frequency among the groups with and 
without a history of concussion: 37% of participants in the non-concussed group were APOE-ε4 carrier 













3.2 Oculomotor tasks 
Results from a two-sample t-test comparing the groups with and without a history of concussion are 
shown in Table 2. There were no significant differences between the groups, therefore, this variable was 
not analysed further.  
 
Prosaccades. Figure 1 shows the distributions of prosaccade promptness (1/latency) and prosaccade 
latency using a reciprobit plot  in APOE-ε4 carriers and non-carriers. Statistical analysis confirmed a 
significant main effect of APOE genotype (F(1,95) = 7.38, p=0.008; ɳp2 =0.13). Mean saccade latency was 
190±28 ms for the APOE-ε4 carriers compared to 174±24 ms for the non-carrier group (Figure 2). 
Results from the Wilcoxon two-sample test were also significant (Z=2.56, p=0.010). The median 
saccade latency and corresponding interquartile range were 175 ms (158-188 ms) for non-carriers, and 
184 ms (166-205 ms) for ε4 carriers. Table 3 shows the results of analysis on subpopulations of saccades 
in the express range (80-134ms), fast regular range (135-180 ms), and slow regular range (181-400 ms). 
There were no participants in the ε4 carrier group whose saccade latencies were in the express range, 
and only 3% of non-carrier participants exhibited express saccades. The majority (65%) of non-carrier 
participants had saccade latency in the fast regular range. In contrast, 43% of carriers had saccade 
latency in the fast regular range, and 57% had a saccade latency in the slow range. Therefore, the 
subanalysis indicates a shift towards longer prosaccade latency in the APOE-ε4 carriers. 
Analysis using the LATER model confirmed a significant effect of genotype on parameter µ 
(F(1,95) = 7.66, p=0.007; ɳp2 =0.14), and no significant effect on parameter σ (F(1,95) = 1.60, p=0.209; ɳp2 
=0.03). These results suggest that the delay in saccade latency in the APOE-ε4 group is due to a lower 













significant differences were found between APOE genotypes for prosaccade amplitude or peak velocity 
(Table 4).       
 
 
Antisaccades.  There was no significant main effect of APOE genotype for antisaccade latency (F(1,95) = 
0.31, p=0.581; ɳp2 =0.01), or mean percentage of errors (i.e., saccades in the wrong direction;  F(1,95) = 
0.37, p=0.545; ɳp2 =0.01).  Non-significant results were also obtained with the Wilcoxon test (Z=-0.51, 
p=0.610). Antisaccade latency was 255±27 ms for the APOE-ε4 carriers compared to 251±35 ms for the 
non-carrier group (Figure 2). The percentage of errors was also comparable in both groups, APOE-ε4: 
17.8±13% vs. non-carrier: 19.5±14%. Results from the Wilcoxon two-sample test were also non-
significant (Z=0.94, p=0.346). The median saccade latency and corresponding interquartile range were 
244 ms (228-269 ms) for non-carriers, and 256 ms (234-279 ms) for ε4 carriers Analysis using the 
LATER model showed no significant effect of genotype on parameter µ (F(1,95) = 0.61, p=0.438; ɳp2 
=0.01), and no significant effect on parameter σ (F(1,95) = 3.40, p=0.068 ɳp2 =0.07). There were no 
significant differences between APOE genotypes for antisaccade amplitude or peak velocity (Table 4).     
  
4.0 Discussion 
The main aim of this study was to assess the influence of APOE genotype on saccade latency in young 
adults. Our results show that latency was significantly longer only for the prosaccade task in a group of 
APOE-ε4 carriers when compared to a non-carrier group. In contrast, there was no difference among the 
genotypes for antisaccade latency or error rate. We will discuss these findings in the context of the 
neural circuitry involved in the generation of saccades, and in particular, the influence of the cholinergic 













Our study provides the first evidence that APOE genotype has a significant influence on prosaccade 
latency in a young cohort. Saccadic eye movements have been studied extensively in humans and animal models 
using a variety of experimental paradigms [45], which show that saccade latency is highly task dependent [46-
48]. The current study used a step paradigm, and saccade latency interquartile range was as expected, between 
158 and 195 ms, with <5% of all eye movements in the express saccade range (i.e., <135 ms). Our results 
showed that prosaccade latency is ~16 ms longer in APOE-ε4 carriers, which corresponds to a medium effect 
size. Similar magnitude effects have been previously reported for saccade latency across different experimental 
manipulations. For example, saccade latency is reliably longer by ~15-20 ms during monocular compared to 
binocular viewing [49-51]. In the current study, all participants were tested under identical experimental 
conditions; therefore, our results provide an important new contribution to the literature by identifying that a 
single individual/genetic factor, APOE polymorphism, has a significant influence on prosaccade initiation. 
Importantly, the increase in saccade latency is within the normal range of prosaccade latencies; therefore, it 
does not represent a deficit in the group of young individuals tested in the current study. Future studies should 
assess saccade latency in older individuals because this outcome measure may be useful in establishing the 
APOE behavioural phenotype.    
A key neural structure involved in the generation of saccadic eye movements is the superior 
colliculus (SC). Experimental and computational work indicates that a saccade is initiated when the 
activity of a saccade neuron in the SC reaches a threshold firing rate [52, 53], which has led researchers 
to propose a stochastic accumulator model to explain initiation of saccadic eye movements [31]. In 
accordance with this model, increased latency could be associated with a reduced rate of signal 
accumulation and/or lower level of baseline activity in the saccade neurons. In support of the model, 
when the stimulus appearance is less predictable, the SC saccade neurons exhibit less activity, and 













appearance would affect parameter σ, while change in the accumulation rate would be reflected by 
parameter µ. Our analysis confirmed that APOE-ε4 genotype is associated with a lower signal 
accumulation rate, rather than a change in baseline firing rate.  
The SC receives direct input from brainstem cholinergic regions, specifically the parabigeminal 
nucleus which projects to the superficial (visual) layers, and the pedunculopontine tegmental nucleus 
(PPTN) which projects to the deeper (motor) layers. These cholinergic inputs terminate in zones that 
receive multiple afferent inputs, for example, from the frontal eye fields, the parietal cortex, and the 
basal ganglia; therefore, it is possible that cholinergic inputs are involved in modulation of signal 
transmission. Support for this hypothesis was provided by Kobayashi et al in an experiment which 
showed that application of Ach agonist lowered the threshold firing rate of saccade SC neurons resulting 
in generation of express saccades [36]. Our behavioural results do not support a shift in saccade latency 
distribution towards the express saccades, and results from the LATER model showed no difference in 
parameter σ, which suggests that the APOE genotype does not significantly affect the baseline activity 
of collicular neurons during a prosaccade task. To summarize, our results indicate that APOE genotype 
does not have a drastic effect on the cholinergic projection to the deeper SC layers, at least in the cohort 
of young individuals. Instead, the shift in distribution towards longer latencies was subtle, and latency 
remained within the range of regular saccades.   
In addition to direct projections to the superior colliculus, cholinergic neurons have widespread 
projection to multiple cortical areas involved in sensorimotor and cognitive processing, including 
attentional enhancement of sensory processing [55-57]. Specifically, PPTN cholinergic neurons 
projecting to SC bifurcate and send collateral to the lateral geniculate nucleus [58]; therefore, they can 
influence visual processing at a very early stage, perhaps by increasing the perceptual salience of visual 













hypothesis that optimization of task-related sensory processing is mediated by the cholinergic system 
(for review see: [56, 57, 59]). In light of the fact that APOE polymorphism affects the activity of choline 
acetyltransferase, it is possible that the baseline cholinergic function is lower in individuals with the ε4 
allele. Consequently, the relatively hypocholinergic state would reduce the efficiency of feedforward 
afferent transmission leading to longer saccade latency in ε4 carriers [58]. This interpretation is 
consistent with the results from the LATER model, which showed that the delay in prosaccade latency is 
due to a lower signal accumulation rate. Moreover, our results are consistent with another study that 
examined the effects of the APOE genotype on attention shifting using a Posner-type paradigm and a 
manual button press response in a young cohort similar in age to our sample [16]. Although the effects 
did not reach statistical significance, response latency was ~30 ms slower on validly cued trials in a 
group of ε4 carriers compared to non-carriers. Lack of significance could have risen because the sample 
size was relatively small (i.e., n=41), and the inherent variability in manual reaction time is significantly 
higher in comparison to the variability found for saccade latency distributions. To summarize, the 
cholinergic system is integral for generating orienting/reflexive responses, and a reduced cholinergic 
function seems to be associated with a longer latency of responding. Our study clearly shows that only 
reflexive responses tend to be prolonged in individuals with the ε4 genotype, which maybe due to 
reduced cholinergic activity. Importantly, our results do not support a general deficit in speed of 
information processing because the increased latency was only found in the prosaccade task.  
Interestingly, the ε4 genotype was not associated with antisaccade latency or error rate. The lack 
of association between antisaccade latency and APOE genotype is consistent with the findings from 
Velichkovsky et al [34]. These results can be explained by considering that initiation of saccades 
depends on an extensive neural network including parietal and frontal areas, which influence the activity 













initiation of eye movements depends on the balance of excitatory and inhibitory inputs to the SC. 
Because the initiation of prosaccades and antisaccades involves different neural circuits [60], these 
circuits may be differentially dependent on/influenced by the cholinergic system. For example, 
prefrontal areas show increased activation during antisaccades as compared to prosaccades. Although 
the frontal cortex receives cholinergic input, studies have also shown that the signalling in the prefrontal 
cortex is gated by the dopaminergic system [61, 62]. It is possible that the cholinergic system has a 
greater influence on the neural circuit involved in prosaccade initiation, whereas generation of 
antisaccades relies more on dopaminergic system function [63]. There is no indication in the literature 
that the APOE genotype affects the dopamine system, which may be the reason why antisaccade 
performance is not affected by this polymorphism.  
The effect of APOE genotype on cognitive performance and brain function has been studied 
extensively with the goal of establishing the cognitive/behavioural phenotype that could lead to early 
detection of AD [11]. Because the presence of APOE-ε4 allele is significantly associated with a dose 
dependent occurrence of late onset AD, most studies to date used highly cognitive tasks involving 
episodic memory, working memory, or attention, which are significantly impaired early in the disease 
process [64]. Increased saccade latency has been also reported in patients with autopsy-confirmed AD 
[65], however, no studies to date examined the influence of APOE polymorphism on prosaccade latency 
in ε4 carriers. As highlighted in the review by Lancaster et al [11], cognitive performance and neural 
function in apparently healthy APOE-ε4 carriers seems to be highly age-dependent. Specifically, studies 
with participants older than 60 years showed that the ε4 allele is associated with lower memory scores 
and higher neural activation. In contrast, studies with younger participants showed the reverse effect: 
APOE-ε4 carriers scored better on memory and attention tests. Moreover, when ε4 carriers and non-













indicative of more efficient/economic use of neural resources [13]. These findings are consistent with 
the antagonistic pleiotropy hypothesis whereby the ε4 allele is associated with improved cognitive 
function at a younger age and reduced cognition at an older age. The cognitive phenotype associated 
with APOE genotype therefore is expected to vary across the lifespan, although more studies are 
required to definitively establish this effect. Eye movements can be easily assessed, and therefore, can 
provide further insight into the APOE behavioural phonotype and the associated mechanisms that may 
be disrupted by AD. 
There are several limitations in our study that need to be acknowledged. First, the sample of 
participants tested in this study consisted only of university students, and the results might not generalize 
to randomly recruited participants from a community sample where the level of education might vary 
considerably. Although the Hardy-Weinberg test was not significant, the percent of ε4 carriers was 
higher than might be expected based on random sampling. This could be explained in light of an 
epidemiological study, which reported that ε4 carriers tend to achieve a higher level of education [17]. 
Another limitation of this work regards the use of the LATER model It has been recommended that 200-
300 trials should be used with this analysis; however, our dataset consists of 50-60 trials per participant. 
We used the Kolmogorv-Smirnov test to confirm the model’s goodness of fit to ensure that the 
parameters obtained from the LATER analysis were valid; however, some caution should be exercised 
when interpreting the results from the LATER analysis. Finally, and most importantly, saccade latency 
could be influenced by many polymorphisms in addition to the APOE genotype. Future studies should 
examine the interaction between APOE genotype and other genetic polymorphisms that influence 
function of the cholinergic system. 
In conclusion, this is the first study to show that APOE genotype has a significant influence on 













carriers, this increase does not represent a general deficit in information processing. In fact, in light of 
the antagonistic pleiotropy hypothesis, we propose that the increased saccade latency in young 
individuals could have a positive effect on information processing. Specifically, individuals with the ε4 
allele may be less likely to make erroneous eye movements to salient, but behaviourally irrelevant 
stimuli. These individuals might also have longer fixation durations, and fixation duration has been 
associated with deeper encoding and better recall accuracy [66]. Our recent work also indicates that eye 
movements disrupt the encoding of a spatial sequence, and reduce the span of working memory [24]. 
Therefore, increased saccade latency, as well as fewer eye movements, may provide a benefit for 
cognitive processing in young individuals. However, the basal forebrain cholinergic system is highly 
susceptible to age-related decline [67]. Although this decline will occur regardless of APOE genotype, 
the rate of decline may be accelerated in individuals with the ε4 allele due to greater effects on the 
dysregulation of cortical cholinergic transmission. Taken together, results from our study provide a 
strong indication that saccade latency could be used to establish the APOE behavioural phenotype across 
the lifespan, which may have important implications for identifying individuals at a greater risk of 
developing AD.  
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Figure 1: Distributions of prosaccade promptness (1/s) (A), and prosaccade latency using a reciprobit 




Figure 2: Mean saccade latency for the prosaccade and antisaccade tasks in the e4 carrier and non-carrier 
groups. Prosaccade latency was significantly longer in a group of e4 carriers whereas 
antisaccade latency was not significantly affected by genotype. Error bars show standard error 

















Table 1: Demographic information  
Genotype Sex Age (years) Concussion history 
APOE – ε2ε3  M: 6;  F: 5 21.7±1.8 No: 10; Yes: 1 
APOE – ε2ε4 M: 0;  F: 1 22.0 No: 1; Yes: 0 
APOE – ε3ε3 M: 26;  F: 25 22.3±3.0 No: 34; Yes: 17 
APOE – ε3ε4 M: 14;  F: 17 23.7±3.7 No: 23; Yes: 8 
APOE – ε4ε4 M: 2;  F: 1 24.0±2.4 No: 2; Yes: 1 
 
 
Table 2: Descriptive statistics for saccade latency and errors in the groups with and without a history of 
concussion. 
 No concussion history 
(n=70) 
















177±25 174  
(159-191) 
187±29 182  
(172-195) 






249±31 248  
(228-269) 
261±34 257  
(241-287) 







17.9±13.3 13.3  
(6.9-28.3) 
21.5±13.7 20.3  
(6.7-30) 






Table 3: Percent of participants and the corresponding descriptive statistics for latency of express  













 APOE genotype (% 
of participants) 
Mean ± Std dev Median (IQR) 
Express saccade latency range 
(80-134 ms)  
Non-carrier (3%) 131±4 131 (129 - 134) 
ε4 carrier (0%) NA NA 
Fast regular saccade latency 
range (135-180 ms) 
Non-carrier (65%) 163±12 164 (154 -174) 
ε4 carrier (43%) 165±9 163 (158-171) 
Slow regular saccade latency 
range (181-400 ms) 
Non-carrier (32%) 201±19 194 (188 -211) 
ε4 carrier (57%) 208±25 203 (191-219) 
 
 
Table 4: Mean amplitude and peak velocity for prosaccades and antisaccades in the non-carrier and ε4 
carrier groups. 
 Saccade amplitude (deg) Saccade peak velocity (deg/sec) 
 Non-carrier ε4 carrier Non-carrier ε4 carrier 
Prosaccade  9.23±1.08 9.25±0.44 329±47 332±43 
Antisaccade 9.92±2.64 9.67±3.34 303±54 297±56 
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